Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial

Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial

An online expert meeting held on November 17, 2021 reviewed the results of the randomized, double-blind, multinational, parallel-group EMPULSE trial, evaluating the clinical benefit and safety of the sodium-glucose co-transporter-2 inhibitor (SGLT2i) empagliflozin compared with placebo in patients h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2022-04-01
Series:	Российский кардиологический журнал
Subjects:	empagliflozin heart failure hospitalization acute decompensated heart failure empulse trial win ratio analysis
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4945
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution
by: S. A. Boytsov, et al.
Published: (2023-05-01)

Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial
by: G. P. Arutyunov, et al.
Published: (2020-12-01)

Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization
by: D. P. Golubovskaya, et al.
Published: (2023-05-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology
by: V. N. Larina, et al.
Published: (2023-12-01)

Relationships and Activities. The study is supported by OOO AstraZeneca Pharmaceuticals.
by: E. V. Shlyakhto, et al.
Published: (2023-07-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)

Management of health care for patients with heart failure in the Northwestern, North Caucasian, Volga and Southern Federal Districts of the Russian Federation: 6-year changes and future prospects
by: N. E. Zvartau, et al.
Published: (2025-04-01)

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"
by: O. B. Irtyuga, et al.
Published: (2024-06-01)

Anemia in Patients with Heart Failure: Current State of the Problem
by: S. R. Gilyarevsky, et al.
Published: (2019-04-01)

SUCCESSFUL HEART TRANSPLANTATION IN PATIENT WITH CRITICAL MULTIORGAN FAILURE
by: L. A. Bockeria, et al.
Published: (2010-03-01)

Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
by: Vladimir V. Salukhov, et al.
Published: (2016-12-01)

Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients
by: E. V. Shlyakhto, et al.
Published: (2023-11-01)

THE MECHANISMS OF HEART FAILURE DEVELOPMENT IN OBESITY
by: O. V. Gritsenko, et al.
Published: (2018-06-01)

Hyporesponse to statin therapy among patients with acute coronary syndrome: prevalence, impact on the development of heart failure in a short-term follow-up
by: I. V. Druk, et al.
Published: (2022-11-01)

Effect of dapagliflozin in patients with heart failure on reducing cardiovascular mortality in federal project on the prevention of cardiovascular diseases
by: M. V. Zhuravleva, et al.
Published: (2020-11-01)

Oral health and heart failure
by: I. V. Vashurin, et al.
Published: (2012-02-01)

2020 Clinical practice guidelines for Myocarditis in adults
by: G. P. Arutyunov, et al.
Published: (2021-12-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

The experience of 70 heart transplants in a multidisciplinary medical care facility
by: M. Sh. Khubutiya, et al.
Published: (2018-09-01)

Prognostic value of renal function in patients with acute decompensation of chronic heart failure
by: I. A. Meray, et al.
Published: (2008-08-01)

Rationale and design of multicenter prospective observational study of types, GRAde, VariabilITY, associations and prognosis of orthostatic responses in Heart Failure (GRAVITY-HF)
by: E. V. Shlyakhto, et al.
Published: (2020-02-01)

Long-term mortality risk in hospitalized patients with heart failure after myocardial infarction
by: A. S. Galyavich, et al.
Published: (2020-02-01)

WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT?
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure
by: William T. Abraham, et al.
Published: (2025-02-01)

10-year experience in orthotopic heart transplantation in Kuzbass
by: L. S. Barbarash, et al.
Published: (2025-01-01)

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)

Carbohydrate metabolism disorders in patients with heart failure: data from the local registry
by: A. R. Vaisberg, et al.
Published: (2021-04-01)

Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy
by: O. A. Abdullaev, et al.
Published: (2024-03-01)

Efficacy and safety of acetazolamide in patients with NYHA class II-IV decompensated heart failure: protocol of an open-label prospective randomized multicenter study (ORION-A)
by: O. A. Rubanenko, et al.
Published: (2023-09-01)

Experimental evaluation of mechanical heart support system based on viscous friction disc pump
by: A. M. Chernyavskiy, et al.
Published: (2017-04-01)

The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
by: Alexey A. Nekrasov, et al.
Published: (2019-10-01)

Anemia – an independent risk factor of adverse cardiovascular outcomes in women
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Total, ageand sex-specific mortality after discharge of patients with heart failure: the first large-scale cohort real-world study on Russian population
by: A. E. Soloveva, et al.
Published: (2024-06-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

CLINICAL AND ULTRASOUND PREDICTORS OF HEART FAILURE DEVELOPMENT IN PATIENTS WITH SUBACUTE MYOCARDIAL INFARCTION
by: D. Yu. Serdyukov, et al.
Published: (2012-04-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

Influence on the autonomic cardiovascular system regulation in the treatment of hypertension, arrhythmias and heart failure
by: E. V. Shlyakhto, et al.
Published: (2022-09-01)

Features of structural and functional state of the heart in patients with chronic heart failure with comorbid hypertension
by: I. V. Drozdova
Published: (2017-06-01)